The latest research, products, and discoveries from the science industry’s leading companies and company divisions.
Founded by research scientists in 1999, Cell Signaling Technology (CST) is a private, family-owned company headquartered in Danvers, Massachusetts with over 400 employees worldwide. Active in the field of applied systems biology research, particularly as it relates to cancer, CST understands the importance of using antibodies with high levels of specificity and lot-to-lot consistency. Its why we produce all of our antibodies in house, and perform painstaking validations for multiple applications. And the same CST scientists who produce our antibodies also provide technical support for customers, helping them design experiments, troubleshoot, and achieve reliable results. We do this because thats what wed want if we were in the lab. Because, actually, we are.
Cytiva is a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics. Formerly part of GE Healthcare Life Sciences, we have a rich heritage tracing back hundreds of years, and a fresh beginning since 2020. Our customers undertake life-saving activities ranging from fundamental biological research to developing innovative vaccines, biologic drugs, and novel cell and gene therapies. Our job is to supply the tools and services they need to work better, faster and safer, leading to better patient outcomes.
Cellular Dynamics International is a leading developer of fully functional human cells derived from induced pluripotent stem (iPS) cells. Our iCell® and MyCell® products provide industrial quantities of high quality, highly pure human cells enabling disease modeling, drug discovery, toxicity testing, and cell therapy research.
ChemPartner is a global full-service life science CRO/CDMO with over 18 years of pharmaceutical research experience, evolved from the pure chemistry service provider, focusing on research innovation with global reach. As more and more pharmas and biotech companies look for alliance partners to provide intellectual contributions and exceptional technical expertise, ChemPartner is uniquely positioned to not only be a CRO, but to be a true pharmaceutical alliance partner. With a team of over 2000 experienced scientists, hundreds of western-trained pharmaceutical industry leaders, and experienced pharmaceutical executive leadership at the helm, ChemPartner is aligned and dedicated to technically and strategically accomplishing the research initiatives of pharmas and biotech companies worldwide.
Canon BioMedical, a wholly owned subsidiary of Canon U.S.A., Inc., is focused on empowering the biomedical research and healthcare communities by developing, manufacturing, and marketing innovative technologies and solutions. The technologies and solutions developed will help enable clinicians and scientists to improve our health and advance science. Canon BioMedical will continue to pursue innovative solutions in line with Canon's Kyosei philosophy of social and environmental responsibility through the use of existing and emerging Canon technology as well as strategic partnerships.
Ceres Nanosciences is a privately held company, located in Northern Virginia, focused on incorporating its novel Nanotrap® particle technology into a range of diagnostic products and workflows. The Nanotrap® particle technology can improve diagnostic testing by capturing, concentrating, and preserving low abundance analytes from biological samples. The Nanotrap® particle technology was developed with support from the National Institutes of Health (NIH), the Defense Advanced Research Projects Agency (DARPA), the Bill and Melinda Gates Foundation, Schmidt Futures, the Defense Threat Reduction Agency (DTRA), and the Commonwealth of Virginia.
Codex DNA is on a mission to empower scientific researchers in both academic and commercial settings with the hardware, software, materials, and methodologies required to rapidly and accurately write large quantities of synthetic genes. To, in effect, build biology. We are decentralizing DNA synthesis with the world's most innovative portfolio of synthetic biology platform technologies. Our gene synthesis portfolio reduces the turnaround time for synthesizing biology workflows from weeks and months down to days and hours, and includes the BioXp™ 3200 system (the world's first and only gene printer), variant library services, and Gibson Assembly® reagents. In addition to automating, speeding, and optimizing DNA design and synthesis, Codex DNA and the BioXp™ system ensure your designs stay in your hands, marrying speed and security for innovators in drug discovery, vaccine development, DNA data storage, and beyond. Founded by Dan Gibson - the creator of the industry-standard Gibson Assembly® methodology - Codex DNA is attempting nothing less than changing everything.
Carterra® is the leading provider of high throughput technologies designed to accelerate and improve the discovery of novel therapeutic candidates. Carterra's LSA™ instrument, software, and consumables for monoclonal antibody (mAb) characterization deliver up to 100 times the throughput of existing platforms in 10% of the time while using only 1% of the sample required by other systems. The LSA combines patented microfluidics technology with real-time high throughput Surface Plasmon Resonance (HT-SPR) and industry-leading data analysis and visualization software to revolutionize mAb screening. Carterra, Inc. is based in Salt Lake City, Utah, and has Customer Experience Centers in San Francisco, Salt Lake City, Boston, and Munich, Germany. For additional information, please visit www.carterra-bio.com.
Carolina Liquid Chemistries Corp. is a manufacturer, distributor, re packager, and re labeler of chemistry instruments and reagents for use in the clinical chemistry laboratory. Laboratories today are looking to cut costs and retain quality. Carolina Liquid Chemistries helps clinical laboratories accomplish both with reagents for use on a variety of chemistry instruments and attractive service contracts.
At Chembio, our mission is to be a leader in the development, manufacture and commercialization of diagnostic solutions. We are dedicated to delivering exceptional products that provide ease of use, and rapid and accurate results at the point-of-care (POC). As a global company, we are committed to innovation and the highest quality standards.